{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["HDL", "Nitraria retusa", "dyslipidemia", "obesity", "overweight", "triglyceride"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37630839", "DateCompleted": {"Year": "2023", "Month": "08", "Day": "28"}, "DateRevised": {"Year": "2023", "Month": "08", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "20"}], "Language": ["eng"], "ELocationID": ["3649", "10.3390/nu15163649"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "15", "Issue": "16", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "20"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Exploring the Effects of Short-Term Daily Intake of <i>Nitraria retusa</i> Tea on Lipid Profile: A Pre-Post, Uncontrolled Pilot Study in Both Healthy and Overweight/Obese Adults.", "Abstract": {"AbstractText": ["In the present study, we aimed to explore the feasibility, compliance, and potential benefits of <i>Nitraria retusa</i> extract (NRE) intervention in both healthy (BMI \u2264 24.9 Kg/m<sup>2</sup>) and overweight/obese adults (BMI > 25 Kg/m<sup>2</sup>). A total of 98 participants, including 37 healthy individuals and 61 overweight/obese adults, were randomly assigned to either a low-dose (500 mg/day) or a high-dose (2000 mg/day) NRE intervention group. Plasma lipid biomarkers, liver and kidney functions, general hematology, and blood glucose levels were measured at the baseline and 10 days after intervention. While the lipid profile of the healthy participants did not show any statistically significant changes, the obese participants in the high-dose group experienced a significant decrease in triglyceride levels (within-group difference <i>p</i> value = 0.004) and an increase in HDL levels (within-group <i>p</i> value < 0.001). No significant differences were observed in other parameters, indicating that NRE at the given doses was safe. Furthermore, the study had impressive compliance and acceptability, with over 90% of participants completing the intervention and diligently following the study protocol. This pilot study represents the first investigation into the feasibility, acceptability, and potential benefits of NRE intervention on lipid profiles in human volunteers."]}, "AuthorList": [{"Identifier": ["0009-0005-3034-1644"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolic Biophysics and Applied Pharmacology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}, {"Identifier": [], "Affiliation": "USCR Analytical Platform UHPLC-MS & Research in Medicine and Biology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}], "LastName": "Laouani", "ForeName": "Aicha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolic Biophysics and Applied Pharmacology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}, {"Identifier": [], "Affiliation": "USCR Analytical Platform UHPLC-MS & Research in Medicine and Biology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}], "LastName": "Nasrallah", "ForeName": "Hana", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolic Biophysics and Applied Pharmacology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}, {"Identifier": [], "Affiliation": "USCR Analytical Platform UHPLC-MS & Research in Medicine and Biology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}], "LastName": "Sassi", "ForeName": "Awatef", "Initials": "A"}, {"Identifier": ["0000-0003-2816-9118"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba 305-8572, Japan."}, {"Identifier": [], "Affiliation": "Alliance for Research on the Mediterranean and North Africa (ARENA), University of Tsukuba, Tsukuba 305-8572, Japan."}], "LastName": "Ferdousi", "ForeName": "Farhana", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Alliance for Research on the Mediterranean and North Africa (ARENA), University of Tsukuba, Tsukuba 305-8572, Japan."}, {"Identifier": [], "Affiliation": "Laboratory of Aromatic and Medicinal Plants, Center of Biotechnology, Technopark of Borj Cedria, BP 901, Hammam-Lif 2050, Tunisia."}], "LastName": "Kalai", "ForeName": "Feten Zar", "Initials": "FZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Endocrinology-Diabetology Department, Farhat Hached Hospital, Sousse 4003, Tunisia."}], "LastName": "Hasni", "ForeName": "Yosra", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faulty of Medicine, University of Sousse, Sousse 4002, Tunisia."}], "LastName": "Limem", "ForeName": "Khalifa", "Initials": "K"}, {"Identifier": ["0000-0002-1399-9541"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Life and Environmental Sciences, University of Tsukuba, Tsukuba 305-8572, Japan."}, {"Identifier": [], "Affiliation": "Alliance for Research on the Mediterranean and North Africa (ARENA), University of Tsukuba, Tsukuba 305-8572, Japan."}, {"Identifier": [], "Affiliation": "Open Innovation Laboratory for Food and Medicinal Resource Engineering (FoodMed-OIL), National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba 305-8577, Japan."}], "LastName": "Isoda", "ForeName": "Hiroko", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Metabolic Biophysics and Applied Pharmacology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}, {"Identifier": [], "Affiliation": "USCR Analytical Platform UHPLC-MS & Research in Medicine and Biology, Faculty of Medicine, University of Sousse, Sousse 4002, Tunisia."}], "LastName": "Saguem", "ForeName": "Saad", "Initials": "S"}], "GrantList": [{"GrantID": "JPMJSA1506", "Agency": "Japan Science and Technology Agency (JST), Science and Technology Research Partnership for Sustainable Development (SATREPS)", "Country": ""}, {"GrantID": "Not available", "Agency": "Tunisian Ministry of Higher Education and Scientific Research", "Country": ""}], "PublicationTypeList": ["Randomized Controlled Trial", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Lipids"}, {"RegistryNumber": "0", "NameOfSubstance": "Tea"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Overweight"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": [], "DescriptorName": "Obesity"}, {"QualifierName": [], "DescriptorName": "Magnoliopsida"}, {"QualifierName": [], "DescriptorName": "Lipids"}, {"QualifierName": [], "DescriptorName": "Tea"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Censani M., Hammad H.T., Christos P.J., Schumaker T. Vitamin D deficiency associated with markers of cardiovascular disease in children with obesity. Glob. Pediatr. Health. 2018;5:2333794X17751773. doi: 10.1177/2333794X17751773.", "ArticleIdList": ["10.1177/2333794X17751773", "PMC5768258", "29349100"]}, {"Citation": "Nikparvar M., Khaladeh M., Yousefi H., Vahidi Farashah M., Moayedi B., Kheirandish M. Dyslipidemia and its associated factors in southern Iranian women, Bandare-Kong Cohort study, a cross-sectional survey. Sci. Rep. 2021;11:9125. doi: 10.1038/s41598-021-88680-z.", "ArticleIdList": ["10.1038/s41598-021-88680-z", "PMC8080669", "33911149"]}, {"Citation": "Jemaa R., Razgallah R., Ben Ghorbel I., Rais L., Kallel A. Prevalence of cardiovascular risk factors in the Tunisian population: The ATERA-survey. Arch. Cardiovasc. Dis. Suppl. 2020;12:159. doi: 10.1016/j.acvdsp.2019.09.328.", "ArticleIdList": ["10.1016/j.acvdsp.2019.09.328"]}, {"Citation": "Tang N., Ma J., Tao R., Chen Z., Yang Y., He Q., Lv Y., Lan Z., Zhou J. The effects of the interaction between BMI and dyslipidemia on hypertension in adults. Sci. Rep. 2022;12:927. doi: 10.1038/s41598-022-04968-8.", "ArticleIdList": ["10.1038/s41598-022-04968-8", "PMC8766602", "35042940"]}, {"Citation": "Toselli S., Gualdi-Russo E., Boulos D.N., Anwar W.A., Lakhoua C., Jaouadi I., Khyatti M., Hemminki K. Prevalence of overweight and obesity in adults from North Africa. Eur. J. Public Health. 2014;24((Suppl. 1)):31\u201339. doi: 10.1093/eurpub/cku103.", "ArticleIdList": ["10.1093/eurpub/cku103", "25107996"]}, {"Citation": "Holdsworth M., El Ati J., Bour A., Kameli Y., Derouiche A., Millstone E., Delpeuch F. Developing national obesity policy in middle-income countries: A case study from North Africa. Health Policy Plan. 2013;28:858\u2013870. doi: 10.1093/heapol/czs125.", "ArticleIdList": ["10.1093/heapol/czs125", "PMC3854492", "23230285"]}, {"Citation": "Shamai L., Lurix E., Shen M., Novaro G.M., Szomstein S., Rosenthal R., Hernandez A.V., Asher C.R. Association of body mass index and lipid profiles: Evaluation of a broad spectrum of body mass index patients including the morbidly obese. Obes. Surg. 2011;21:42\u201347. doi: 10.1007/s11695-010-0170-7.", "ArticleIdList": ["10.1007/s11695-010-0170-7", "20563664"]}, {"Citation": "Klop B., Elte J.W.F., Cabezas M.C. Dyslipidemia in Obesity: Mechanisms and Potential Targets. Nutrients. 2013;5:1218\u20131240. doi: 10.3390/nu5041218.", "ArticleIdList": ["10.3390/nu5041218", "PMC3705344", "23584084"]}, {"Citation": "She Y., Mangat R., Tsai S., Proctor S.D., Richard C. The interplay of obesity, dyslipidemia and immune dysfunction: A brief overview on pathophysiology, animal models, and nutritional modulation. Front. Nutr. 2022;9:840209. doi: 10.3389/fnut.2022.840209.", "ArticleIdList": ["10.3389/fnut.2022.840209", "PMC8891442", "35252310"]}, {"Citation": "Hussain A., Ali I., Kaleem W.A., Yasmeen F. Correlation between Body Mass Index and Lipid Profile in patients with Type 2 Diabetes attending a tertiary care hospital in Peshawar. Pak. J. Med. Sci. 2019;35:591\u2013597. doi: 10.12669/pjms.35.3.7.", "ArticleIdList": ["10.12669/pjms.35.3.7", "PMC6572993", "31258559"]}, {"Citation": "Goldberg A.C. Combination therapy of dyslipidemia. Curr. Treat. Options Cardiovasc. Med. 2007;9:249\u2013258. doi: 10.1007/s11936-007-0020-7.", "ArticleIdList": ["10.1007/s11936-007-0020-7", "17761110"]}, {"Citation": "Hashempur M.H., Mosavat S.H., Heydari M., Shams M. Medicinal plants\u2019 use among patients with dyslipidemia: An Iranian cross-sectional survey. J. Complement. Integr. Med. 2019;16:20180101. doi: 10.1515/jcim-2018-0101.", "ArticleIdList": ["10.1515/jcim-2018-0101", "30391934"]}, {"Citation": "Upadya H., Prabhu S., Prasad A., Subramanian D., Gupta S., Goel A. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia. BMC Complement. Altern. Med. 2019;19:27. doi: 10.1186/s12906-019-2430-y.", "ArticleIdList": ["10.1186/s12906-019-2430-y", "PMC6341673", "30670010"]}, {"Citation": "Majd F.S., Talebi S.S., Ahmad Abadi A.N., Poorolajal J., Dastan D. Efficacy of a standardized herbal product from Pistacia atlantica subsp. Kurdica in type 2 diabetic patients with hyperlipidemia: A triple-blind randomized clinical trial. Complement. Ther. Clin. Pract. 2022;48:101613. doi: 10.1016/j.ctcp.2022.101613.", "ArticleIdList": ["10.1016/j.ctcp.2022.101613", "35691258"]}, {"Citation": "Chen I.J., Liu C.Y., Chiu J.P., Hsu C.H. Therapeutic effect of high-dose green tea extract on weight reduction: A randomized, double-blind, placebo-controlled clinical trial. Clin. Nutr. 2016;35:592\u2013599. doi: 10.1016/j.clnu.2015.05.003.", "ArticleIdList": ["10.1016/j.clnu.2015.05.003", "26093535"]}, {"Citation": "Iida A., Usui T., Zar Kalai F., Han J., Isoda H., Nagumo Y. Protective effects of Nitraria retusa extract and its constituent isorhamnetin against amyloid \u03b2-induced cytotoxicity and amyloid \u03b2 aggregation. Biosci. Biotechnol. Biochem. 2015;79:1548\u20131551. doi: 10.1080/09168451.2015.1027655.", "ArticleIdList": ["10.1080/09168451.2015.1027655", "25965116"]}, {"Citation": "Rjeibi I., Feriani A., Hentati F., Hfaiedh N., Michaud P., Pierre G. Structural characterization of water-soluble polysaccharides from Nitraria retusa fruits and their antioxidant and hypolipidemic activities. Int. J. Biol. Macromol. 2019;129:422\u2013432. doi: 10.1016/j.ijbiomac.2019.02.049.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.02.049", "30742925"]}, {"Citation": "Cha\u00e2bane M., Koubaa M., Soudani N., Elwej A., Grati M., Jamoussi K., Boudawara T., Ellouze Chaabouni S., Zeghal N. Nitraria retusa fruit prevents penconazole-induced kidney injury in adult rats through modulation of oxidative stress and histopathological changes. Pharm. Biol. 2017;55:1061\u20131073. doi: 10.1080/13880209.2016.1278455.", "ArticleIdList": ["10.1080/13880209.2016.1278455", "PMC6130529", "28198206"]}, {"Citation": "Song L., Liu S., Zhang L., Pan L., Xu L. Polysaccharides from Nitraria retusa Fruit: Extraction, Purification, Structural Characterization, and Antioxidant Activities. Molecules. 2023;28:1266. doi: 10.3390/molecules28031266.", "ArticleIdList": ["10.3390/molecules28031266", "PMC9920977", "36770932"]}, {"Citation": "Mariem C., Sameh M., Nadhem S., Soumaya Z., Najiba Z., Raoudha E.G. Antioxidant and antimicrobial properties of the extracts from Nitraria retusa fruits and their applications to meat product preservation. Ind. Crops Prod. 2014;55:295\u2013303. doi: 10.1016/j.indcrop.2014.01.036.", "ArticleIdList": ["10.1016/j.indcrop.2014.01.036"]}, {"Citation": "Zar Kalai F., Dakhlaoui S., Hammami M., Mkadmini K., Ksouri R., Isoda H. Phenolic compounds and biological activities of different organs from aerial part of Nitraria retusa (Forssk.) Asch.: Effects of solvents. Int. J. Food Prop. 2022;25:1524\u20131538. doi: 10.1080/10942912.2022.2087673.", "ArticleIdList": ["10.1080/10942912.2022.2087673"]}, {"Citation": "Kalai F.Z., Mkadmini K., Hammami M., Isoda H., Ksouri R. Biological and Chemical Research. Vol. 9. Science Signpost Publishing; Newark, DE, USA: 2022. Intensification of phenolic compounds extraction from Nitraria retusa leaves by Ultrasound-Assisted System Using Box\u2013Behnken Design and Evaluation of Biological Activities."}, {"Citation": "Zar Kalai F., Han J., Ksouri R., El Omri A., Abdelly C., Isoda H. Antiobesity effects of an edible halophyte Nitraria retusa Forssk in 3T3-L1 preadipocyte differentiation and in C57B6J/L mice fed a high fat diet-induced obesity. Evid.-Based Complement. Altern. Med. 2013;2013:368658. doi: 10.1155/2013/368658.", "ArticleIdList": ["10.1155/2013/368658", "PMC3866713", "24367387"]}, {"Citation": "Kalai F.Z., Han J., Ksouri R., Abdelly C., Isoda H. Oral administration of Nitraria retusa ethanolic extract enhances hepatic lipid metabolism in db/db mice model \u2018BKS. Cg-Dock7m+/+ Leprdb/J\u2019through the modulation of lipogenesis\u2013lipolysis balance. Food Chem. Toxicol. 2014;72:247\u2013256. doi: 10.1016/j.fct.2014.07.029.", "ArticleIdList": ["10.1016/j.fct.2014.07.029", "25086370"]}, {"Citation": "Zhang T., Chen J., Tang X., Luo Q., Xu D., Yu B. Interaction between adipocytes and high-density lipoprotein:new insights into the mechanism of obesity-induced dyslipidemia and atherosclerosis. Lipids Health Dis. 2019;18:223. doi: 10.1186/s12944-019-1170-9.", "ArticleIdList": ["10.1186/s12944-019-1170-9", "PMC6913018", "31842884"]}, {"Citation": "Anagnostis P., Stevenson J.C., Crook D., Johnston D.G., Godsland I.F. Effects of menopause, gender and age on lipids and high-density lipoprotein cholesterol subfractions. Maturitas. 2015;81:62\u201368. doi: 10.1016/j.maturitas.2015.02.262.", "ArticleIdList": ["10.1016/j.maturitas.2015.02.262", "25804951"]}, {"Citation": "Wilson P.W., Anderson K.M., Harri T., Kannel W.B., Castelli W.P. Determinants of change in total cholesterol and HDL-C with age: The Framingham Study. J. Gerontol. 1994;49:M252\u2013M257. doi: 10.1093/geronj/49.6.M252.", "ArticleIdList": ["10.1093/geronj/49.6.M252", "7963277"]}, {"Citation": "Bayram F., Kocer D., Gundogan K., Kaya A., Demir O., Coskun R., Sabuncu T., Karaman A., Cesur M., Rizzo M., et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J. Clin. Lipidol. 2014;8:206\u2013216. doi: 10.1016/j.jacl.2013.12.011.", "ArticleIdList": ["10.1016/j.jacl.2013.12.011", "24636181"]}, {"Citation": "Nofer J.-R., Kehrel B., Fobker M., Levkau B., Assmann G., von Eckardstein A. HDL and arteriosclerosis: Beyond reverse cholesterol transport. Atherosclerosis. 2002;161:1\u201316. doi: 10.1016/S0021-9150(01)00651-7.", "ArticleIdList": ["10.1016/S0021-9150(01)00651-7", "11882312"]}, {"Citation": "Harman J.L., Griswold M.E., Jeffries N.O., Sumner A.E., Sarpong D.F., Akylbekova E.L., Walker E.R., Wyatt S.B., Taylor H.A., Jr. Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: The Jackson Heart Study. J. Clin. Lipidol. 2011;5:173\u2013178. doi: 10.1016/j.jacl.2011.02.002.", "ArticleIdList": ["10.1016/j.jacl.2011.02.002", "PMC3100667", "21600522"]}, {"Citation": "Anderson R.A., Broadhurst C.L., Polansky M.M., Schmidt W.F., Khan A., Flanagan V.P., Schoene N.W., Graves D.J. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J. Agric. Food Chem. 2004;52:65\u201370. doi: 10.1021/jf034916b.", "ArticleIdList": ["10.1021/jf034916b", "14709014"]}, {"Citation": "Nabavi S.M., Nabavi S.F., Eslami S., Moghaddam A.H. In vivo protective effects of quercetin against sodium fluoride-induced oxidative stress in the hepatic tissue. Food Chem. 2012;132:931\u2013935. doi: 10.1016/j.foodchem.2011.11.070.", "ArticleIdList": ["10.1016/j.foodchem.2011.11.070"]}, {"Citation": "Bansal P., Paul P., Mudgal J., Nayak P.G., Pannakal S.T., Priyadarsini K., Unnikrishnan M. Antidiabetic, antihyperlipidemic and antioxidant effects of the flavonoid rich fraction of Pilea microphylla (L.) in high fat diet/streptozotocin-induced diabetes in mice. Exp. Toxicol. Pathol. 2012;64:651\u2013658. doi: 10.1016/j.etp.2010.12.009.", "ArticleIdList": ["10.1016/j.etp.2010.12.009", "21208790"]}, {"Citation": "Graf D., Seifert S., Jaudszus A., Bub A., Watzl B. Anthocyanin-rich juice lowers serum cholesterol, leptin, and resistin and improves plasma fatty acid composition in fischer rats. PLoS ONE. 2013;8:e66690. doi: 10.1371/journal.pone.0066690.", "ArticleIdList": ["10.1371/journal.pone.0066690", "PMC3688949", "23825152"]}, {"Citation": "Alam M., Juraimi A.S., Rafii M., Abdul Hamid A., Aslani F., Hasan M., Mohd Zainudin M.A., Uddin M. Evaluation of antioxidant compounds, antioxidant activities, and mineral composition of 13 collected purslane (Portulaca oleracea L.) accessions. BioMed Res. Int. 2014;2014:296063. doi: 10.1155/2014/296063.", "ArticleIdList": ["10.1155/2014/296063", "PMC3918865", "24579078"]}, {"Citation": "Okafor I.A., Ezejindu D. Phytochemical studies on Portulaca oleracea (purslane) plant. GJBAHS. 2014;3:132\u2013136."}, {"Citation": "Rodr\u00edguez-Rodr\u00edguez C., Torres N., Guti\u00e9rrez-Uribe J.A., Noriega L.G., Torre-Villalvazo I., Leal-D\u00edaz A.M., Antunes-Ricardo M., M\u00e1rquez-Mota C., Ordaz G., Chavez-Santoscoy R.A. The effect of isorhamnetin glycosides extracted from Opuntia ficus-indica in a mouse model of diet induced obesity. Food Funct. 2015;6:805\u2013815. doi: 10.1039/C4FO01092B.", "ArticleIdList": ["10.1039/C4FO01092B", "25588195"]}, {"Citation": "Jiang H., Yamashita Y., Nakamura A., Croft K., Ashida H. Quercetin and its metabolite isorhamnetin promote glucose uptake through different signalling pathways in myotubes. Sci. Rep. 2019;9:2690. doi: 10.1038/s41598-019-38711-7.", "ArticleIdList": ["10.1038/s41598-019-38711-7", "PMC6389993", "30804434"]}, {"Citation": "Chbili C., Maoua M., Selmi M., Mrad S., Khairi H., Limem K., Mrizek N., Saguem S., Ben Fredj M. Evaluation of Daily Laurus nobilis Tea Consumption on Lipid Profile Biomarkers in Healthy Volunteers. J. Am. Coll. Nutr. 2020;39:733\u2013738. doi: 10.1080/07315724.2020.1727787.", "ArticleIdList": ["10.1080/07315724.2020.1727787", "32213118"]}, {"Citation": "Khan A., Zaman G., Anderson R.A. Bay leaves improve glucose and lipid profile of people with type 2 diabetes. J. Clin. Biochem. Nutr. 2009;44:52\u201356. doi: 10.3164/jcbn.08-188.", "ArticleIdList": ["10.3164/jcbn.08-188", "PMC2613499", "19177188"]}, {"Citation": "Ghislain M.T., Gis\u00e9le E.L., Bertrand P.M.J., Mathieu F., Honor\u00e9 F.K., F\u00e9licit\u00e9 T.M., Inocent G. Effect of \u201cFol\u00e9r\u00e9\u201d juice (calyx of Hibiscus sabdariffa Lin) on some biochemical parameters in humans. Pak. J. Nutr. 2011;10:755\u2013759. doi: 10.3923/pjn.2011.755.759.", "ArticleIdList": ["10.3923/pjn.2011.755.759"]}, {"Citation": "Sanguinetti S.M., Brites F.D., Fasulo V., Verona J., Elbert A., Wikinski R.L., Schreier L.E. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients. Diabetes Nutr. Metab. 2001;14:27\u201336.", "ArticleIdList": ["11345163"]}, {"Citation": "Brites F., Martin M., Guillas I., Kontush A. Antioxidative activity of high-density lipoprotein (HDL): Mechanistic insights into potential clinical benefit. BBA Clin. 2017;8:66\u201377. doi: 10.1016/j.bbacli.2017.07.002.", "ArticleIdList": ["10.1016/j.bbacli.2017.07.002", "PMC5597817", "28936395"]}, {"Citation": "Soran H., Schofield J.D., Durrington P.N. Antioxidant properties of HDL. Front. Pharmacol. 2015;6:222. doi: 10.3389/fphar.2015.00222.", "ArticleIdList": ["10.3389/fphar.2015.00222", "PMC4607861", "26528181"]}, {"Citation": "Cooney M., Dudina A., De Bacquer D., Wilhelmsen L., Sans S., Menotti A., De Backer G., Jousilahti P., Keil U., Thomsen T. HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis. 2009;206:611\u2013616. doi: 10.1016/j.atherosclerosis.2009.02.041.", "ArticleIdList": ["10.1016/j.atherosclerosis.2009.02.041", "19375079"]}, {"Citation": "Ouimet M., Barrett T.J., Fisher E.A. HDL and reverse cholesterol transport: Basic mechanisms and their roles in vascular health and disease. Circ. Res. 2019;124:1505\u20131518. doi: 10.1161/CIRCRESAHA.119.312617.", "ArticleIdList": ["10.1161/CIRCRESAHA.119.312617", "PMC6813799", "31071007"]}, {"Citation": "Chukwurah M.I., Miller M. Fibrates, Hypertriglyceridemia, and CVD Risk: Where Do We Stand After the PROMINENT Trial for Triglyceride Lowering? Curr. Cardiol. Rep. 2023:1\u20136. doi: 10.1007/s11886-023-01926-2.", "ArticleIdList": ["10.1007/s11886-023-01926-2", "37505399"]}, {"Citation": "Klimentidis Y.C., Chougule A., Arora A., Frazier-Wood A.C., Hsu C.-H. Triglyceride-increasing alleles associated with protection against type-2 diabetes. PLoS Genet. 2015;11:e1005204. doi: 10.1371/journal.pgen.1005204.", "ArticleIdList": ["10.1371/journal.pgen.1005204", "PMC4447354", "26020539"]}, {"Citation": "Ginsberg H.N., Zhang Y.-L., Hernandez-Ono A. Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes. Arch. Med. Res. 2005;36:232\u2013240. doi: 10.1016/j.arcmed.2005.01.005.", "ArticleIdList": ["10.1016/j.arcmed.2005.01.005", "15925013"]}, {"Citation": "Yamashita S., Masuda D., Matsuzawa Y. Pemafibrate, a new selective PPAR\u03b1 modulator: Drug concept and its clinical applications for dyslipidemia and metabolic diseases. Curr. Atheroscler. Rep. 2020;22:5. doi: 10.1007/s11883-020-0823-5.", "ArticleIdList": ["10.1007/s11883-020-0823-5", "PMC6978439", "31974794"]}, {"Citation": "Joseph J.-P., Afonso M., Berda\u00ef D., Salles N., B\u00e9nard A., Gay B., Bonnet F. B\u00e9n\u00e9fices et risques des statines en pr\u00e9vention primaire chez la personne \u00e2g\u00e9e. La Presse M\u00e9dicale. 2015;44:1219\u20131225. doi: 10.1016/j.lpm.2015.09.015.", "ArticleIdList": ["10.1016/j.lpm.2015.09.015", "26585744"]}, {"Citation": "Lorenzati B., Zucco C., Miglietta S., Lamberti F., Bruno G. Oral hypoglycemic drugs: Pathophysiological basis of their mechanism of actionoral hypoglycemic drugs: Pathophysiological basis of their mechanism of action. Pharmaceuticals. 2010;3:3005\u20133020. doi: 10.3390/ph3093005.", "ArticleIdList": ["10.3390/ph3093005", "PMC4034109", "27713388"]}, {"Citation": "Harper C., Jacobson T. Avoiding statin myopathy: Understanding key drug interactions. Clin. Lipidol. 2011;6:665\u2013674. doi: 10.2217/clp.11.57.", "ArticleIdList": ["10.2217/clp.11.57"]}, {"Citation": "Sorrentino M.J. An update on statin alternatives and adjuncts. Clin. Lipidol. 2012;7:721\u2013730."}, {"Citation": "van Dam R.M., Willett W.C., Manson J.E., Hu F.B. The relationship between overweight in adolescence and premature death in women. Ann. Intern. Med. 2006;145:91\u201397. doi: 10.7326/0003-4819-145-2-200607180-00006.", "ArticleIdList": ["10.7326/0003-4819-145-2-200607180-00006", "16847291"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "22"}, {"Year": "2023", "Month": "8", "Day": "11"}, {"Year": "2023", "Month": "8", "Day": "18"}, {"Year": "2023", "Month": "8", "Day": "28", "Hour": "6", "Minute": "41"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "10", "Minute": "47"}, {"Year": "2023", "Month": "8", "Day": "26", "Hour": "1", "Minute": "27"}, {"Year": "2023", "Month": "8", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["37630839", "PMC10459123", "10.3390/nu15163649", "nu15163649"]}}], "PubmedBookArticle": []}